NCT05135351

Study Using Prebiotics to Improve Gut Microbiome Diversity After Autologous Cellular Therapy

RecruitingNAINTERVENTIONAL

Trial Details

Start: 2022-05-13Est. Completion: 2028-07

Enrollment target: 30 participants

Locations

Contact

LeukemiaLymphomaMultiple MyelomaMyelodysplastic Syndromes (MDS)Myeloproliferative Neoplasm

Cancer and treatment-related cognitive changes, such as thinking or remembering, hinder resumption of normal routine and…

Omaha, United StatesEst. completion Jul 2027

Relapsed or Refractory Multiple Myeloma

Multiple myeloma (MM) is a plasma cell malignancy characterized by the proliferation of clonal plasma cells in the bone …

Tucson, United StatesEst. completion Feb 2033

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.